{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:38:16Z","timestamp":1790800696302,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Crescentic rapidly progressive glomerulonephritis (RPGN) represents the most aggressive form of acquired glomerular disease. While most therapeutic approaches involve potentially toxic immunosuppressive strategies, the pathophysiology remains incompletely understood. Podocytes are glomerular epithelial cells that are normally growth-arrested because of the expression of cyclin-dependent kinase (CDK) inhibitors. An exception is in RPGN where podocytes undergo a deregulation of their differentiated phenotype and proliferate. Here we demonstrate that microRNA-92a (miR-92a) is enriched in podocytes of patients and mice with RPGN. The CDK inhibitor p57\n                    <jats:sup>Kip2<\/jats:sup>\n                    is a major target of\n                    <jats:italic>miR-92a<\/jats:italic>\n                    that constitutively safeguards podocyte cell cycle quiescence. Podocyte-specific deletion of\n                    <jats:italic>miR-92a<\/jats:italic>\n                    in mice de-repressed the expression of p57\n                    <jats:sup>Kip2<\/jats:sup>\n                    and prevented glomerular injury in RPGN. Administration of an anti-miR-92a after disease initiation prevented albuminuria and kidney failure, indicating miR-92a inhibition as a potential therapeutic strategy for RPGN. We demonstrate that miRNA induction in epithelial cells can break glomerular tolerance to immune injury.\n                  <\/jats:p>","DOI":"10.1038\/s41467-017-01885-7","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T11:23:07Z","timestamp":1511349787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis"],"prefix":"10.1038","volume":"8","author":[{"given":"Carole","family":"Henique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Boll\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Loyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Grahammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Dhaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vernerey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Guyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Lazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Bensaada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Legr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Akira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bruneval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Dimmeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Tedgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Nochy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mesnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Lenoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-5905","authenticated-orcid":false,"given":"Pierre-Louis","family":"Tharaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"1885_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0272-6386(88)80079-9","volume":"11","author":"WG Couser","year":"1988","unstructured":"Couser, W. G. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am. J. Kidney Dis. \n                           11, 449\u2013464 (1988).","journal-title":"Am. J. Kidney Dis."},{"key":"1885_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/ndt\/16.suppl_6.80","volume":"16","author":"JC Jennette","year":"2001","unstructured":"Jennette, J. C. & Thomas, D. B. Crescentic glomerulonephritis. Nephrol. Dial. Transplant. \n                           16, 80\u201382 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1885_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.15231755.2005.00503.x","volume":"68","author":"J Bariety","year":"2005","unstructured":"Bariety, J. et al. Podocyte involvement in human immune crescentic glomerulonephritis. Kidney Int. \n                           68, 1109\u20131119 (2005).","journal-title":"Kidney Int."},{"key":"1885_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1681\/ASN.2006101115","volume":"19","author":"PS Thorner","year":"2008","unstructured":"Thorner, P. S., Ho, M., Eremina, V., Sado, Y. & Quaggin, S. Podocytes contribute to the formation of glomerular crescents. J. Am. Soc. Nephrol. \n                           19, 495\u2013502 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1885_CR5","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1681\/ASN.2009010122","volume":"20","author":"B Smeets","year":"2009","unstructured":"Smeets, B. et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J. Am. Soc. Nephrol. \n                           20, 2604\u20132615 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1885_CR6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1046\/j.1523-1755.2001.00057.x","volume":"60","author":"K Hiromura","year":"2001","unstructured":"Hiromura, K. et al. Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int. \n                           60, 2235\u20132246 (2001).","journal-title":"Kidney Int."},{"key":"1885_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1053\/S0270-9295(03)00133-5","volume":"23","author":"SV Griffin","year":"2003","unstructured":"Griffin, S. V. et al. The role of cell cycle proteins in glomerular disease. Semin. Nephrol. \n                           23, 569\u2013582 (2003).","journal-title":"Semin. Nephrol."},{"key":"1885_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1523-1755.2000.00149.x","volume":"58","author":"L Barisoni","year":"2000","unstructured":"Barisoni, L. et al. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int. \n                           58, 137\u2013143 (2000).","journal-title":"Kidney Int."},{"key":"1885_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s004280050420","volume":"435","author":"K Nitta","year":"1999","unstructured":"Nitta, K. et al. Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis. Virchows Arch. \n                           435, 422\u2013427 (1999).","journal-title":"Virchows Arch."},{"key":"1885_CR10","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0002-9440(10)65739-2","volume":"153","author":"M Nagata","year":"1998","unstructured":"Nagata, M., Nakayama, K., Terada, Y., Hoshi, S. & Watanabe, T. Cell cycle regulation and differentiation in the human podocyte lineage. Am. J. Pathol. \n                           153, 1511\u20131520 (1998).","journal-title":"Am. J. Pathol."},{"key":"1885_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.ASN.0000102468.37809.C6","volume":"15","author":"MJ Moeller","year":"2004","unstructured":"Moeller, M. J. et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J. Am. Soc. Nephrol. \n                           15, 61\u201367 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1885_CR12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nm1460","volume":"12","author":"M Ding","year":"2006","unstructured":"Ding, M. et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat. Med. \n                           12, 1081\u20131087 (2006).","journal-title":"Nat. Med."},{"key":"1885_CR13","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.2491","volume":"17","author":"G Bollee","year":"2011","unstructured":"Bollee, G. et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat. Med. \n                           17, 1242\u20131250 (2011).","journal-title":"Nat. Med."},{"key":"1885_CR14","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1038\/sj.jid.5700385","volume":"126","author":"A Mirmohammadsadegh","year":"2006","unstructured":"Mirmohammadsadegh, A. et al. STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases. J. Invest. Dermatol. \n                           126, 2272\u20132280 (2006).","journal-title":"J. Invest. Dermatol."},{"key":"1885_CR15","doi-asserted-by":"publisher","first-page":"13704","DOI":"10.1073\/pnas.93.24.13704","volume":"93","author":"OK Park","year":"1996","unstructured":"Park, O. K., Schaefer, T. S. & Nathans, D. In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc. Natl Acad. Sci. USA \n                           93, 13704\u201313708 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1885_CR16","first-page":"3923","volume":"63","author":"H Shao","year":"2003","unstructured":"Shao, H., Cheng, H. Y., Cook, R. G. & Tweardy, D. J. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res. \n                           63, 3923\u20133930 (2003).","journal-title":"Cancer Res."},{"key":"1885_CR17","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1071545","volume":"296","author":"DS Aaronson","year":"2002","unstructured":"Aaronson, D. S. & Horvath, C. M. A road map for those who don't know JAK-STAT. Science \n                           296, 1653\u20131655 (2002).","journal-title":"Science"},{"key":"1885_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm.3142","volume":"19","author":"CA Gebeshuber","year":"2013","unstructured":"Gebeshuber, C. A. et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat. Med. \n                           19, 481\u2013487 (2013).","journal-title":"Nat. Med."},{"key":"1885_CR19","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He, L. et al. A microRNA polycistron as a potential human oncogene. Nature \n                           435, 828\u2013833 (2005).","journal-title":"Nature"},{"key":"1885_CR20","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","volume":"324","author":"A Bonauer","year":"2009","unstructured":"Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science \n                           324, 1710\u20131713 (2009).","journal-title":"Science"},{"key":"1885_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/ATVBAHA.112.300415","volume":"33","author":"D Kaluza","year":"2013","unstructured":"Kaluza, D. et al. Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells. Arterioscler. Thromb. Vasc. Biol. \n                           33, 533\u2013543 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1885_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2013.12.025","volume":"323","author":"M Li","year":"2014","unstructured":"Li, M. et al. miR-92a family and their target genes in tumorigenesis and metastasis. Exp. Cell Res. \n                           323, 1\u20136 (2014).","journal-title":"Exp. Cell Res."},{"key":"1885_CR23","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","volume":"104","author":"M Brock","year":"2009","unstructured":"Brock, M. et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17\/92 pathway. Circ. Res. \n                           104, 1184\u20131191 (2009).","journal-title":"Circ. Res."},{"key":"1885_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cell.2008.04.001","volume":"133","author":"JT Mendell","year":"2008","unstructured":"Mendell, J. T. miRiad roles for the miR-17-92 cluster in development and disease. Cell \n                           133, 217\u2013222 (2008).","journal-title":"Cell"},{"key":"1885_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2013.197","volume":"84","author":"Y Dai","year":"2013","unstructured":"Dai, Y. et al. Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis. Kidney Int. \n                           84, 950\u2013961 (2013).","journal-title":"Kidney Int."},{"key":"1885_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","volume":"39","author":"D Iliopoulos","year":"2010","unstructured":"Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L. & Struhl, K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell \n                           39, 493\u2013506 (2010).","journal-title":"Mol. Cell"},{"key":"1885_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood-2007-03-081133","volume":"110","author":"D Loffler","year":"2007","unstructured":"Loffler, D. et al. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood \n                           110, 1330\u20131333 (2007).","journal-title":"Blood"},{"key":"1885_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/bjc.2013.349","volume":"109","author":"HY Lin","year":"2013","unstructured":"Lin, H. Y., Chiang, C. H. & Hung, W. C. STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells. Br. J. Cancer \n                           109, 731\u2013738 (2013).","journal-title":"Br. J. Cancer"},{"key":"1885_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/onc.2011.222","volume":"31","author":"LY Bourguignon","year":"2012","unstructured":"Bourguignon, L. Y., Earle, C., Wong, G., Spevak, C. C. & Krueger, K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan\/CD44-activated head and neck squamous cell carcinoma cells. Oncogene \n                           31, 149\u2013160 (2012).","journal-title":"Oncogene"},{"key":"1885_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.8140422","volume":"264","author":"Z Zhong","year":"1994","unstructured":"Zhong, Z., Wen, Z. & Darnell, J. E. Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science \n                           264, 95\u201398 (1994).","journal-title":"Science"},{"key":"1885_CR31","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1172\/JCI3785","volume":"102","author":"JR Grandis","year":"1998","unstructured":"Grandis, J. R. et al. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. J. Clin. Invest. \n                           102, 1385\u20131392 (1998).","journal-title":"J. Clin. Invest."},{"key":"1885_CR32","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1172\/JCI31871","volume":"117","author":"SP Gao","year":"2007","unstructured":"Gao, S. P. et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J. Clin. Invest. \n                           117, 3846\u20133856 (2007).","journal-title":"J. Clin. Invest."},{"key":"1885_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.8272872","volume":"263","author":"C Lutticken","year":"1994","unstructured":"Lutticken, C. et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science \n                           263, 89\u201392 (1994).","journal-title":"Science"},{"key":"1885_CR34","first-page":"37","volume":"12","author":"T Kishimoto","year":"1994","unstructured":"Kishimoto, T. Signal transduction through homo- or heterodimers of gp130. Stem Cells \n                           12, 37\u201344 (1994).","journal-title":"Stem Cells"},{"key":"1885_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1128\/MCB.13.1.276","volume":"13","author":"UM Wegenka","year":"1993","unstructured":"Wegenka, U. M., Buschmann, J., Lutticken, C., Heinrich, P. C. & Horn, F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell Biol. \n                           13, 276\u2013288 (1993).","journal-title":"Mol. Cell Biol."},{"key":"1885_CR36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. \n                           13, 1235\u20131242 (2006).","journal-title":"Chem. Biol."},{"key":"1885_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4939-1062-5_25","volume":"1182","author":"H Dweep","year":"2014","unstructured":"Dweep, H., Gretz, N. & Sticht, C. miRWalk database for miRNA-target interactions. Methods Mol. Biol. \n                           1182, 289\u2013305 (2014).","journal-title":"Methods Mol. Biol."},{"key":"1885_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell \n                           120, 15\u201320 (2005).","journal-title":"Cell"},{"key":"1885_CR39","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1101\/gad.9.6.650","volume":"9","author":"S Matsuoka","year":"1995","unstructured":"Matsuoka, S. et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. \n                           9, 650\u2013662 (1995).","journal-title":"Genes Dev."},{"key":"1885_CR40","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1101\/gad.9.6.639","volume":"9","author":"MH Lee","year":"1995","unstructured":"Lee, M. H., Reynisdottir, I. & Massague, J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. \n                           9, 639\u2013649 (1995).","journal-title":"Genes Dev."},{"key":"1885_CR41","doi-asserted-by":"crossref","first-page":"F515","DOI":"10.1152\/ajprenal.2000.278.4.F515","volume":"278","author":"SJ Shankland","year":"2000","unstructured":"Shankland, S. J. & Wolf, G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am. J. Physiol. Renal Physiol. \n                           278, F515\u2013F529 (2000).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1885_CR42","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Krutzfeldt","year":"2005","unstructured":"Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature \n                           438, 685\u2013689 (2005).","journal-title":"Nature"},{"key":"1885_CR43","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/CIRCULATIONAHA.113.001904","volume":"128","author":"R Hinkel","year":"2013","unstructured":"Hinkel, R. et al. Inhibition of microRNA-92a protects against ischemia\/reperfusion injury in a large-animal model. Circulation \n                           128, 1066\u20131075 (2013).","journal-title":"Circulation"},{"key":"1885_CR44","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1182\/blood-2010-01-264812","volume":"115","author":"C Doebele","year":"2010","unstructured":"Doebele, C. et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood \n                           115, 4944\u20134950 (2010).","journal-title":"Blood"},{"key":"1885_CR45","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCRESAHA.114.302213","volume":"114","author":"X Loyer","year":"2014","unstructured":"Loyer, X. et al. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ. Res. \n                           114, 434\u2013443 (2014).","journal-title":"Circ. Res."},{"key":"1885_CR46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cell.2015.07.008","volume":"162","author":"P Du","year":"2015","unstructured":"Du, P., Wang, L., Sliz, P. & Gregory, R. I. A biogenesis step upstream of microprocessor controls miR-17 approximately 92 expression. Cell \n                           162, 885\u2013899 (2015).","journal-title":"Cell"},{"key":"1885_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00020.2002","volume":"83","author":"H Pavenstadt","year":"2003","unstructured":"Pavenstadt, H., Kriz, W. & Kretzler, M. Cell biology of the glomerular podocyte. Physiol. Rev. \n                           83, 253\u2013307 (2003).","journal-title":"Physiol. Rev."},{"key":"1885_CR48","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1101\/gad.12.20.3162","volume":"12","author":"P Zhang","year":"1998","unstructured":"Zhang, P., Wong, C., DePinho, R. A., Harper, J. W. & Elledge, S. J. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev. \n                           12, 3162\u20133167 (1998).","journal-title":"Genes Dev."},{"key":"1885_CR49","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1046\/j.1523-1755.2000.00213.x","volume":"58","author":"SJ Shankland","year":"2000","unstructured":"Shankland, S. J. et al. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int. \n                           58, 674\u2013683 (2000).","journal-title":"Kidney Int."},{"key":"1885_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/sj.ki.5001577","volume":"70","author":"T Srivastava","year":"2006","unstructured":"Srivastava, T., Garola, R. E. & Singh, H. K. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Kidney Int. \n                           70, 529\u2013535 (2006).","journal-title":"Kidney Int."},{"key":"1885_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.ajkd.2003.09.010","volume":"43","author":"S Wang","year":"2004","unstructured":"Wang, S., Kim, J. H., Moon, K. C., Hong, H. K. & Lee, H. S. Cell-cycle mechanisms involved in podocyte proliferation in cellular lesion of focal segmental glomerulosclerosis. Am. J. Kidney Dis. \n                           43, 19\u201327 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"1885_CR52","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/ndt\/gfg231","volume":"18","author":"J Bariety","year":"2003","unstructured":"Bariety, J. et al. Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol. Dial. Transplant. \n                           18, 1777\u20131784 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1885_CR53","first-page":"71","volume":"43","author":"E Kemeny","year":"1995","unstructured":"Kemeny, E., Mihatsch, M. J., Durmuller, U. & Gudat, F. Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis. Clin. Nephrol. \n                           43, 71\u201383 (1995).","journal-title":"Clin. Nephrol."},{"key":"1885_CR54","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1681\/ASN.2013010012","volume":"24","author":"A Pozzi","year":"2013","unstructured":"Pozzi, A. & Zent, R. Integrins in kidney disease. J. Am. Soc. Nephrol. \n                           24, 1034\u20131039 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1885_CR55","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm.4362","volume":"23","author":"SS Hayek","year":"2017","unstructured":"Hayek, S. S. et al. A tripartite complex of suPAR, APOL1 risk variants and alphavbeta3 integrin on podocytes mediates chronic kidney disease. Nat. Med. \n                           23, 945\u2013953 (2017).","journal-title":"Nat. Med."},{"key":"1885_CR56","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa035471","volume":"349","author":"MJ Roman","year":"2003","unstructured":"Roman, M. J. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. \n                           349, 2399\u20132406 (2003).","journal-title":"N. Engl. J. Med."},{"key":"1885_CR57","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/acr.20433","volume":"63","author":"R Suppiah","year":"2011","unstructured":"Suppiah, R. et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res \n                           63, 588\u2013596 (2011).","journal-title":"Arthritis Care Res"},{"key":"1885_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrneph.2012.107","volume":"8","author":"N Wall","year":"2012","unstructured":"Wall, N. & Harper, L. Complications of long-term therapy for ANCA-associated systemic vasculitis. Nat. Rev. Nephrol. \n                           8, 523\u2013532 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"1885_CR59","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/art.24957","volume":"60","author":"MD Morgan","year":"2009","unstructured":"Morgan, M. D. et al. Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum. \n                           60, 3493\u20133500 (2009).","journal-title":"Arthritis Rheum."},{"key":"1885_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/gene.10164","volume":"35","author":"MJ Moeller","year":"2003","unstructured":"Moeller, M. J., Sanden, S. K., Soofi, A., Wiggins, R. C. & Holzman, L. B. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis \n                           35, 39\u201342 (2003).","journal-title":"Genesis"},{"key":"1885_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis \n                           45, 593\u2013605 (2007).","journal-title":"Genesis"},{"key":"1885_CR62","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/labinvest.3700630","volume":"87","author":"A Moh","year":"2007","unstructured":"Moh, A. et al Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab. Invest. \n                           87, 1018\u20131028 (2007).","journal-title":"Lab. Invest."},{"key":"1885_CR63","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1681\/ASN.V1481998","volume":"14","author":"T Shigehara","year":"2003","unstructured":"Shigehara, T. et al. Inducible podocyte-specific gene expression in transgenic mice. J. Am. Soc. Nephrol. \n                           14, 1998\u20132003 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1885_CR64","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvu162","volume":"103","author":"JM Daniel","year":"2014","unstructured":"Daniel, J. M. et al. Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc. Res. \n                           103, 564\u2013572 (2014).","journal-title":"Cardiovasc. Res."},{"key":"1885_CR65","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ki.2013.522","volume":"85","author":"J Huang","year":"2014","unstructured":"Huang, J. et al. Lutheran\/basal cell adhesion molecule accelerates progression of crescentic glomerulonephritis in mice. Kidney Int. \n                           85, 1123\u20131136 (2014).","journal-title":"Kidney Int."},{"key":"1885_CR66","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1681\/ASN.2014111080","volume":"27","author":"C Henique","year":"2016","unstructured":"Henique, C. et al. Nuclear factor erythroid 2-related factor 2 drives podocyte-specific expression of peroxisome proliferator-activated receptor gamma essential for resistance to crescentic GN. J. Am. Soc. Nephrol. \n                           27, 172\u2013188 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1885_CR67","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","volume":"161","author":"M Takemoto","year":"2002","unstructured":"Takemoto, M. et al. A new method for large scale isolation of kidney glomeruli from mice. Am. J. Pathol. \n                           161, 799\u2013805 (2002).","journal-title":"Am. J. Pathol."},{"key":"1885_CR68","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/ki.2012.487","volume":"83","author":"M Boerries","year":"2013","unstructured":"Boerries, M. et al. Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks. Kidney Int. \n                           83, 1052\u20131064 (2013).","journal-title":"Kidney Int."},{"key":"1885_CR69","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1681\/ASN.2013020195","volume":"25","author":"O Lenoir","year":"2014","unstructured":"Lenoir, O. et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. J. Am. Soc. Nephrol \n                           25, 1050\u20131062 (2014).","journal-title":"J. Am. Soc. Nephrol"},{"key":"1885_CR70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.33549\/physiolres.932410","volume":"62","author":"A Sengul","year":"2013","unstructured":"Sengul, A., Santisuk, R., Xing, W. & Kesavan, C. Systemic administration of an antagomir designed to inhibit miR-92, a regulator of angiogenesis, failed to modulate skeletal anabolic response to mechanical loading. Physiol. Res. \n                           62, 221\u2013226 (2013).","journal-title":"Physiol. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01885-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01885-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01885-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:19:11Z","timestamp":1671733151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01885-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01885-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]},"assertion":[{"value":"1 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1829"}}